Development, License Deal For BSG005
Sept 25 (Reuters) - Biosergen AB BIOSGN.ST :
* BIOSERGEN AND ALKEM LABORATORIES LTD COLLABORATES TO DEVELOP ANTI-INFECTIVE FOR SEVERE
FUNGAL
INFECTIONS
* SIGNING OF A CO-DEVELOPMENT AND LICENSE AGREEMENT FOR BSG005, AN INNOVATIVE POLYENE
MACROLIDE,
THROUGH PHASE II AND PHASE III TRIALS FOR SALE IN INDIAN MARKET
Source text for Eikon: ID:nWkr8VV3kr
Further company coverage: BIOSGN.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))